Long-term survival for myeloid neoplasms and national health expenditure: a EUROCARE-6 retrospective, population-based study

Vener C, Lillini R, De Angelis R, Bonfarnuzzo S, Poirel HA, Trama A, et al. the EUROCARE-6 Working Group (Marcos R, Solans M)

Eur J Cancer. 2025; 16;115231. https://doi.org/10.1016/j.ejca.2025.115231 (2025 Impact Factor: 4.300, PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 66/443 Q1).